ADC Therapeutics SA ADCT
1.56 USD +0.02 (+1.30%)
Nov 3, 2026, 3:59 PM EST
1.53 Day range 1.66
0.78 52-week range 4.98
- YTD
- -55.81%
- 1 year
- -62.68%
Analyst view
Consensus: buy
Buy
Price target (mean) 8.40 +438.5% upside
Now 1.56
- Target (low)
- 6.00
- Target (mean)
- 8.40
- Target (high)
- 10.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
- Strong buy2
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 18.85M | +12.3% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 19.60M | +8.6% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 72.72M | +4.6% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 81.25M | +11.7% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 12, 2024 | Guggenheim | Reiterated | Buy | Buy |
| Dec 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 8, 2024 | Stephens & Co. | Initiated | — | Overweight |
| Aug 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 7, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| May 30, 2024 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 7, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 5, 2024 | Guggenheim | Reiterated | — | Buy |
| Mar 28, 2024 | Guggenheim | Initiated | — | Buy |
| Mar 14, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Mar 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 26, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 20, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 20, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 9, 2023 | TD Cowen | Downgrade | Outperform | Market Perform |
| Nov 8, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 19, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 12, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 10, 2023 | JP Morgan | Upgrade | Underweight | Neutral |
| Aug 9, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 25, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 11, 2023 | Morgan Stanley | Reiterated | Equal-Weight | Equal-Weight |
| Jun 20, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 10, 2023 | RBC Capital | Maintained | — | Outperform |
| Apr 24, 2023 | B of A Securities | Downgrade | Neutral | Underperform |
| Feb 13, 2023 | RBC Capital | Maintained | — | Outperform |
| Jan 24, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 4, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 14, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |